TRHC Chairman and CEO to Present at National Community Pharmacist Association Annual Meeting
October 23 2019 - 8:00AM
Tabula Rasa HealthCare®,
Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology
company advancing the field of medication safety, announces today
TRHC Founder, Chairman and CEO Calvin H. Knowlton, PhD, will be
providing a Continuing Education (CE) program for attendees during
the National Community Pharmacist Association’s 2019 Annual
Convention and Expo, October 26 – 29, in San Diego, California. The
2019 theme: Changing the Pharmacy Payment Model. Dr. Knowlton’s CE
program, entitled “New Ways to Identify and Mitigate Adverse Drug
Events and Get Paid for It,” is scheduled for Saturday, October 26
from 1:15p.m. – 2:45p.m. The question to be answered for community
pharmacists attending: “What’s more valuable than knowing how
multiple drug interactions can occur – in particular, when
medications are given simultaneously?”
As a follow up to Saturday’s CE program, Dr. Calvin H. Knowlton
and the teams from Tabula Rasa HealthCare and its subsidiary,
PrescribeWellness®, will host “New Ways to Identify and Mitigate
Adverse Drug Events and Get Paid for It: Practical Application.”
Attendees will take a deeper look into medication risk
stratification and the medication decision support tools that can
be used to identify patients who are at high-risk for adverse drug
events and prioritize risk mitigation efforts. This program will be
held Sunday, October 27 from 11:45a.m. – 1:00p.m. in Room 7AB of
the San Diego Convention Center.
This marks the official launch of TRHC’s lead offering MedWise™
and the MedWise Risk Score™, along with the training of pharmacists
as MedWise Advisors™, in the community pharmacy setting. TRHC’s
goal is to positively impact the lives of patients who are taking
multiple chronic medications and are at risk of multi-drug
interactions that can cause adverse drug events. Adverse drug
events, if it were a disease, would be the 3rd leading cause of
death in the United States, accounting for an estimated 173,000
deaths in 2018, not including other morbidity such as disabilities
that require nursing home placement. “Helping our PrescribeWellness
network of pharmacies keep their patients in the community by
identifying and mitigating medication risk is a priority for Tabula
Rasa HealthCare,” said Dr. Calvin H. Knowlton. “Our goal is to
enable PrescribeWellness community pharmacists to demonstrate
improved outcomes the way TRHC has been able to in other healthcare
sectors through the use of MedWise. People visit community
pharmacies up to 35 times per year. Pharmacists are in a unique
position to improve health.” The National Community
Pharmacists Association, founded in 1898, represents America’s
community pharmacists, including the owners of more than 22,000
pharmacies. The nation’s community pharmacies, pharmacy franchises,
and regional chains dispense approximately 40 percent of the
nation’s retail prescription medications. Learn more by visiting
the National Community Pharmacists Association 2018 digest
at https://www.ncpanet.org/home/ncpa-digest.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) is a leader in providing
patient-specific, data-driven technology and solutions that enable
healthcare organizations to optimize performance to improve patient
outcomes, reduce hospitalizations, lower healthcare costs, and
manage risk. Medication risk management is TRHC’s lead offering,
and its cloud-based software applications, including EireneRx® and
MedWiseTM, provide solutions for a range of payers, providers, and
other healthcare organizations. For more information please visit
www.tabularasahealthcare.com.
About PrescribeWellness
TRHC’s PrescribeWellness is a leading cloud-based patient
relationship management solutions company that facilitates
collaboration between more than 10,000 pharmacies, payers,
providers, pharmaceutical companies and their patients for better
health. For more information on PrescribeWellness products please
visit tabularasahealthcare.com/our-solutions/technology-products/.
Forward-Looking Statements
This press release includes forward-looking statements that we
believe to be reasonable as of today’s date, including statements
regarding Medication Risk Mitigation technology. Such statements
are identified by use of the words “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,”
“should,” and similar expressions. These forward-looking statements
are based on management’s expectations and assumptions as of the
date of this press release. Actual results might differ materially
from those explicit or implicit in the forward-looking statements.
Important factors that could cause actual results to differ
materially include: the need to innovate and provide useful
products and services; risks related to changing healthcare and
other applicable regulations; increasing consolidation in the
healthcare industry; managing our growth effectively; our ability
to adequately protect our intellectual property; and the other risk
factors set forth from time to time in our filings with the SEC,
including those factors discussed under the caption “Risk Factors”
in our most recent annual report on Form 10-K, filed with the SEC
on March 1, 2019, and in subsequent reports filed with or furnished
to the SEC, copies of which are available free of charge within the
Investor Relations section of the TRHC website http://ir.trhc.com
or upon request from our Investor Relations Department. Any
forward-looking statement speaks only as of the date on which it
was made. TRHC assumes no obligation and does not intend to update
these forward-looking statements, except as required by law, to
reflect events or circumstances occurring after today’s date.
Media ContactsDianne
Semingsondsemingson@trhc.comT: (215) 870-0829Amanda
BednarABednar@trhc.comT: (856) 912-5714 |
InvestorsBob East or Asher
DewhurstWestwicke Partnerstabularasa@westwicke.comT: (443)
213-0500 |
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Jul 2023 to Jul 2024